(Q33832917)

29 July 2017

1 reference

title

GIP biology and fat metabolism (English)

1 reference

29 July 2017

Yip RG

1

1 reference

PubMed ID

10666005

29 July 2017

Wolfe MM

series ordinal

2

1 reference

PubMed ID

10666005

29 July 2017

language of work or name

English

0 references

publication date

1 January 2000

1 reference

29 July 2017

1 reference

29 July 2017

66

1 reference

29 July 2017

91-103

1 reference

29 July 2017

2

1 reference

The further purification of motilin, a gastric motor activity stimulating polypeptide from the mucosa of the small intestine of hogs.

29 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900314-8

Further purification of a polypeptide demonstrating enterogastrone activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900314-8

A Gastric Inhibitory Polypeptide II: The Complete Amino Acid Sequence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900314-8

Cellular localization of gastric inhibitory polypeptide in the duodenum and jejunum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900314-8

Identification of the intestinal cell storing gastric inhibitory peptide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900314-8

Electronimmunocytochemical evidence for the K cell localization of gastric inhibitory polypeptide (GIP) im man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900314-8

Stimulation of insulin secretion by gastric inhibitory polypeptide in man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900314-8

Nutrient regulation of the enteroinsular axis and insulin secretion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900314-8

Gastric emptying in Mexican Americans compared to non-Hispanic whites.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900314-8

chimeric peptides define the structural requirements for specific ligand-receptor interaction of GLP-1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900314-8

Molecular cloning of rat glucose-dependent insulinotropic peptide (GIP)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900314-8

Isolation of three antibacterial peptides from pig intestine: gastric inhibitory polypeptide (7-42), diazepam-binding inhibitor (32-86) and a novel factor, peptide 3910.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900314-8

The glucagon superfamily: precursor structure and gene organization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900314-8

pH regulation in barnacle muscle fibers: dependence on intracellular and extracellular pH

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900314-8

Insulinotropic properties of synthetic human gastric inhibitory polypeptide in man: interactions with glucose, phenylalanine, and cholecystokinin-8

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900314-8

The pharmacokinetics of porcine glucose-dependent insulinotropic polypeptide (GIP) in man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900314-8

Dipeptidyl-peptidase IV hydrolyses gastric inhibitory polypeptide, glucagon-like peptide-1(7-36)amide, peptide histidine methionine and is responsible for their degradation in human serum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900314-8

The enteroinsular axis in dipeptidyl peptidase IV-negative rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900314-8

Gastric inhibitory polypeptide receptor, a member of the secretin- vasoactive intestinal peptide receptor family, is widely distributed in peripheral organs and the brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900314-8

Hamster gastric inhibitory polypeptide receptor expressed in pancreatic islets and clonal insulin-secreting cells: its structure and functional properties

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900314-8

Molecular cloning, functional expression, and signal transduction of the GIP-receptor cloned from a human insulinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900314-8

Gastric inhibitory polypeptide receptor in hamster pancreatic beta cells. Direct cross-linking, solubilization and characterization as a glycoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900314-8

The GIP receptor on pancreatic beta cell tumor: molecular identification by covalent cross-linking

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900314-8

Glucagon.glucagon-like peptide I receptor chimeras reveal domains that determine specificity of glucagon binding

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900314-8

Highly conserved aspartate 68, tryptophane 73 and glycine 109 in the N-terminal extracellular domain of the human VIP receptor are essential for its ability to bind VIP.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900314-8

Mutational analysis of cysteine residues within the extracellular domains of the human vasoactive intestinal peptide (VIP) 1 receptor identifies seven mutants that are defective in VIP binding.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900314-8

Exchange of W39 by A within the N-terminal extracellular domain of the GLP-1 receptor results in a loss of receptor function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900314-8

Five out of six tryptophan residues in the N-terminal extracellular domain of the rat GLP-1 receptor are essential for its ability to bind GLP-1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900314-8

Properties of chimeric secretin and VIP receptor proteins indicate the importance of the N-terminal domain for ligand discrimination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900314-8

Impaired cytosolic Ca2+ response to glucose and gastric inhibitory polypeptide in pancreatic beta-cells from triphenyltin-induced diabetic hamster

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900314-8

A wortmannin-sensitive signal transduction pathway is involved in the stimulation of insulin release by vasoactive intestinal polypeptide and pituitary adenylate cyclase-activating polypeptide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900314-8

Glucose-dependent insulinotropic polypeptide stimulates insulin secretion via increased cyclic AMP and [Ca2+]1 and a wortmannin-sensitive signalling pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900314-8

Gastric inhibitory polypeptide activates MAP kinase through the wortmannin-sensitive and -insensitive pathways

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900314-8

Gastric inhibitory polypeptide-dependent cortisol hypersecretion--a new cause of Cushing's syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900314-8

Food-dependent Cushing's syndrome mediated by aberrant adrenal sensitivity to gastric inhibitory polypeptide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900314-8

Food-dependent Cushing's syndrome resulting from abundant expression of gastric inhibitory polypeptide receptors in adrenal adenoma cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900314-8

Gastric inhibitory polypeptide (GIP) binding sites in rat brain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900314-8

The effects of gastric inhibitory polypeptide (GIP) on the release of anterior pituitary hormones.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900314-8

Excessive Insulin Response to Glucose in Obese Subjects as Measured by Immunochemical Assay

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900314-8

The Significance of Basal Insulin Levels in the Evaluation of the Insulin Response to Glucose in Diabetic and Nondiabetic Subjects*

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900314-8

Insulin secretion in obesity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900314-8

Plasma insulin and growth hormone levels in obesity and diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900314-8

Gastric inhibitory polypeptide (GIP) and insulin in obesity: Increased response to stimulation and defective feedback control of serum levels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900314-8

Abnormalities of small intestinal endocrine cells in non-obese diabetic mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900314-8

Immunoreactive gastric inhibitory polypeptide and K cell hyperplasia in obese hyperglycaemic (ob/ob) mice fed high fat and high carbohydrate cafeteria diets.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900314-8

Plasma immunoreactive gastric inhibitory polypeptide in obese hyperglycaemic (ob/ob) mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900314-8

Glucagon-like peptide-1 (7-36)amide and glucose-dependent insulinotropic polypeptide secretion in response to nutrient ingestion in man: acute post-prandial and 24-h secretion patterns.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900314-8

Impaired feedback control of fat induced gastric inhibitory polypeptide (GIP) secretion by insulin in obesity and glucose intolerance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900314-8

New concepts in the pathogenesis and treatment of noninsulin-dependent diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900314-8

Dose-response relation between plasma-insulin and blood-glucose levels during oral glucose loads in prediabetic and diabetic subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900314-8

Plasma Insulin Responses to Oral and Intravenous Glucose: Studies in Normal and Diabetic Subjects*

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900314-8

Gastric Inhibitory Polypeptide in Obesity and Diabetes Mellitus*

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900314-8

Disparity between glucose-dependent insulinotropic polypeptide and insulin responses in obese man.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900314-8

The incretin concept today

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900314-8

Preserved incretin activity of glucagon-like peptide 1 [7-36 amide] but not of synthetic human gastric inhibitory polypeptide in patients with type-2 diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900314-8

Human gastric inhibitory polypeptide receptor: cloning of the gene (GIPR) and cDNA

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900314-8

Effects of gastric inhibitory polypeptide on glucose and lipid metabolism of isolated rat adipocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900314-8

Direct metabolic effects of gastric inhibitory polypeptide (GIP): dissociation at physiological levels of effects on insulin-stimulated fatty acid and glucose incorporation in rat adipose tissue

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900314-8

Gastric inhibitory polypeptide enhancement of the insulin effect on fatty acid incorporation into adipose tissue in the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900314-8

Influence of peptides associated with the gastrointestinal tract on ovine perirenal fat lipogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900314-8

Effect of the entero-pancreatic hormones, gastric inhibitory polypeptide and glucagon-like polypeptide-1(7-36) amide, on fatty acid synthesis in explants of rat adipose tissue

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900314-8

Inhibition of actions of glucagon in adipocytes by gastric inhibitory polypeptide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900314-8

Effect of gastric inhibitory polypeptide on plasma levels of chylomicron triglycerides in dogs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900314-8

Effect of Exogenous or Endogenous Gastric Inhibitory Polypeptide (GIP) on Plasma Triglyceride Responses in Rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900314-8

Functional GIP receptors are present on adipocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900314-8

The effects of gastric inhibitory polypeptide and insulin on fatty acid uptake in adipose tissue are not mediated through cyclic AMP in lean and obese Zucker rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900314-8

10.1016/S0024-3205(99)00314-8

7 January 2021

Identifiers

DOI

1 reference

29 July 2017

1 reference

PubMed ID

10666005